{"transactions":[{"id":3436414,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-16T18:35:58.000Z","date":"2019-08-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 40,000 shares of common stock, became exercisable as to one-half of the award on each of the first anniversary of the date of grant and the second anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":4.5,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001144204-19-040380","document":"tv527778_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419040380/tv527778_4.xml","form_type":"4"}},{"id":3436413,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-16T18:35:58.000Z","date":"2019-08-14","kind":"exercise","acquired":true,"shares":5000,"price":4.5,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) the following Restricted Stock Units (\"RSUs\") that will be settled into common stock upon a \"Change In Control,\" as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 20,000 RSUs granted on March 15, 2018 and (b) 100,000 RSUs granted on May 11, 2017; (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant and the first and second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and that will be settled into common stock upon vesting: (a) 8,134 RSUs granted on July 22, 2019 and unvested as of the date hereof, (b) 3,080 RSUs granted on March 4, 2019 and unvested as of the date hereof and (c) 4,667 RSUs granted on February 28, 2018 and unvested as of the date hereof; and (iii) 13,051 shares of common stock owned by the reporting person, inclusive of the 5,000 shares of common stock reported on this Form 4."}],"balance_after":148932,"source":{"system":"sec-edgar","filing":"0001144204-19-040380","document":"tv527778_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419040380/tv527778_4.xml","form_type":"4"}},{"id":3456853,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-25T00:17:17.000Z","date":"2019-07-22","kind":"grant","acquired":true,"shares":48700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was granted pursuant to the Plan. The shares underlying the stock option vest as to one-quarter of the award on each of the date of grant, the first anniversary of the date of grant, the second anniversary of the date of grant and the third anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":48700,"derivative":{"exercise_price":7.33,"expiration_date":"2029-07-22","underlying":"Common Stock","underlying_shares":48700},"source":{"system":"sec-edgar","filing":"0001144204-19-035841","document":"tv525807_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419035841/tv525807_4.xml","form_type":"4"}},{"id":3456852,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-25T00:17:17.000Z","date":"2019-07-22","kind":"grant","acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") which shall vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) the following RSUs that will be settled into common stock upon a \"Change In Control\" of CytoSorbents Corporation, as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the \"Plan\"): (a) 20,000 RSUs granted on March 15, 2018 and (b) 100,000 RSUs granted on May 11, 2017; (ii) the following RSUs subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting: (a) 12,200 RSUs granted on July 22, 2019 and reported on this Form 4, (b) 4,667 RSUs granted on February 28, 2018 and unvested as of the date hereof and (c) 3,080 RSUs granted on March 4, 2019 and unvested as of the date hereof; and (iii) 5,665 shares of common stock owned by the reporting person."}],"balance_after":145612,"source":{"system":"sec-edgar","filing":"0001144204-19-035841","document":"tv525807_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419035841/tv525807_4.xml","form_type":"4"}},{"id":3608694,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-07T02:09:33.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":4620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") which shall vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) the 20,000 RSUs granted on March 15, 2018 that will be settled into common stock upon a \"Change In Control\" of CytoSorbents Corporation, as defined in the 2014 Long-Term Incentive Plan, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and that will be settled into common stock upon vesting: (a) 4,667 RSUs granted on February 28, 2018 and (b) 4,620 RSUs granted on March 4, 2019 and reported on this Form 4, and (iii) 4,879 shares of common stock owned by the reporting person."}],"balance_after":34166,"source":{"system":"sec-edgar","filing":"0001144204-19-012634","document":"tv515701_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419012634/tv515701_4.xml","form_type":"4"}},{"id":3987805,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-20T14:58:09.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options were granted pursuant to the Plan, and shall vest upon achievement of certain performance goals as determined in the discretion of the Board of Directors of the Company."}],"balance_after":80000,"derivative":{"exercise_price":7.9,"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001144204-18-015762","document":"tv488961_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418015762/tv488961_4.xml","form_type":"4"}},{"id":3987804,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-20T14:58:09.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation (the \"Company\"), as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the \"Plan\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 20,000 RSUs granted on March 15, 2018 and reported on this Form 4, (ii) 14,000 RSUs granted on February 28, 2018, and subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and that will be settled into common stock upon vesting, and (iii) 2,500 shares of common stock owned by the reporting person."}],"balance_after":36500,"source":{"system":"sec-edgar","filing":"0001144204-18-015762","document":"tv488961_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418015762/tv488961_4.xml","form_type":"4"}},{"id":4020442,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-03T00:27:24.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which shall vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares of common stock owned by the reporting person and 14,000 restricted stock units granted on February 28, 2018 and reported on this Form 4."}],"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001144204-18-012644","document":"tv487692_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418012644/tv487692_form4.xml","form_type":"4"}},{"id":4283936,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":155431,"kind":"person","name":"Mortensen Eric R.","position":1,"cik":"0001708454","reported_name":"Mortensen Eric R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-06-13T22:18:36.000Z","date":"2017-06-09","kind":"purchase","acquired":true,"shares":2500,"price":4.0398,"value":10099.5,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-17-032389","document":"v468859_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417032389/v468859_4.xml","form_type":"4"}}]}